ISI Web of Knowledge Take the next step  
Web of Science®
 
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
Quality of Life assessment in clinical trials - Guidelines and a checklist for protocol writers: The UK Medical Research Council experience
Author(s): Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R
Source: EUROPEAN JOURNAL OF CANCER    Volume: 33    Issue: 1    Pages: 20-28    Published: JAN 1997  
Times Cited: 68     References: 44     
Abstract: Many clinical trials groups now routinely consider including Quality of Life (QoL) assessment in trials. Indeed, several have policies stating that QoL should be considered as a potential endpoint in all new trials and that if it is not to be evaluated the applicants should justify not doing so. However, inclusion of QoL in clinical trials presents a number of difficult organisational issues, and serious problems in compliance have frequently been reported. Thus, in multicentre clinical trials many of the expected QoL questionnaires fail to be successfully completed and returned, although a few groups have claimed high success rates. However, it is well. recognised that if questionnaires are missing, there may be bias in the interpretation of trial results, and the estimates of treatment differences and the overall level of QoL may be inaccurate and misleading. Hence it is important to seek methods of improving compliance, at the level of both the participating institution and the patient. We describe a number of methods for addressing these issues, which we suggest should be considered by all those writing clinical trial protocols involving QoL assessment. These are based upon over a decade of experience with assessing QoL in Medical Research Council (MRC) cancer clinical trials. In particular, we provide a checklist for points that should be covered in protocols. Examples are given from a range of current MRC Cancer Trials Office protocols, which it is proposed might act as templates when writing new protocols. (C) 1997 Elsevier Science Ltd.
Document Type: Article
Language: English
Reprint Address: Fayers, PM (reprint author), MRC, CANC TRIALS OFF, 5 SHAFTESBURY RD, CAMBRIDGE CB2 2BW, ENGLAND
Addresses:
1. CHRISTIE HOSP NHS TRUST, PSYCHOL MED GRP, CRC, MANCHESTER M20 4BX, LANCS ENGLAND
Publisher: PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
Subject Category: Oncology
IDS Number: WH230
ISSN: 0959-8049
Previous Record (inactive) Record 1  of  1 Next Record (inactive)
Record from Web of Science®
  
Thomson Reuters Logo